Vivek Nagar, MD
Physical Medicine & Rehabilitation · Oviedo, FLNPI 1689104960
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,409 of the $8,148 with a category attached, or 66.4%. 12 manufacturers reported payments, led by Abbott at 58.5% of the total. Reporting peaked in 2022 at $5,293 and has fallen 77.5% since, to $1,189 in 2025. Among physical medicine & rehabilitation clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $135.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Boston Scientific$1K
- Relievant Medsystems, Inc.$775
- Stryker$589
- Medtronic$215
- Merz North America, Inc.$200
- plus $368 from 6 others
What the payments were for
- Travel & lodging$5,40966%
- Food & beverage$2,73934%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 27 | $4,768 |
| Boston Scientific | 7 | $1,234 |
| Relievant Medsystems, Inc. | 6 | $775 |
| Stryker | 6 | $589 |
| Medtronic | 3 | $215 |
| Merz North America, Inc. | 3 | $200 |
| AbbVie | 1 | $144 |
| Nevro Corp. | 2 | $93 |
| SPR Therapeutics, Inc | 1 | $52 |
| Averitas Pharma Inc. | 2 | $41 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Nalu Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$3,406
- Intracept$2,585
- PRODIGY$1,069
- WaveWriter Alpha Prime 16$951
- SPINEJACK$273
- EMBLEM MRI S-ICD$171
- mild Device Kit$164
- VANTA ADAPTIVESTIM$159
- BOTOX$144
- XEOMIN$142
How this compares
$8,148 in reported general payments places this provider in the 90th percentile of 618 physical medicine & rehabilitation providers in Florida.
See all physical medicine & rehabilitation providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Piroxicam | 25 | $14,253 |
| Calcipotriene | 26 | $7,963 |
| Gabapentin | 205 | $2,237 |
| Tizanidine Hcl | 78 | $800 |
| Celecoxib | 11 | $629 |
| Naproxen | 86 | $593 |
| Methylprednisolone | 75 | $543 |
| Pregabalin | 12 | $487 |
| Methocarbamol | 37 | $398 |
| Duloxetine Hcl | 11 | $316 |
| Cyclobenzaprine Hcl | 33 | $289 |
| Tramadol Hcl | 75 | $216 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $168 |
| Meloxicam | 48 | $103 |
| Alprazolam | 21 | $13 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Oviedo
- Anthony GiuffridaFort Lauderdale$271K
- Ryan HafnerSarasota$164K
- Cassandra ListJacksonville$154K
- Marissa McCarthyTampa$94K
- Jose Medina SanchezTampa$30K
- Alan MillerFernandina Beach$26K
- Anish SoniNaples$25K
- Jose de la TorreWesley Chapel$23K
- Kaivalya DeshpandeMiami$22K
- Ryan RamsookTallahassee$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.